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ROCK inhibitor, Y-27632, reduces FBS-induced
structural alteration in organ-cultured mesenteric
artery
Yang Hoon Huh1,2, Hee-Seok Kweon1* and Toshio Kitazawa2,3*
Abstract
Background: Chronic treatment with fetal bovine serum (FBS) causes gradual vasoconstriction, vascular wall
thickening, and contractility reduction in organ-cultured vascular tissues. We have previously demonstrated that
Rho-associated kinase (ROCK) inhibitors prevent the functional alterations of small arteries in response to the FBS
treatment. Here, we tested a further hypothesis that the chronic inhibition of ROCK has a protective effect on
FBS-induced structural alterations.
Methods: To verify the new hypothesis, the rabbit mesenteric arterial rings were cultured in FBS-supplemented
culture medium with or without Y-27632, a reversible ROCK inhibitor and then western blot,
immunohistochemistry, apoptosis assay, and electron microscopy were performed using organ-cultured arterial
rings.
Results: Chronic treatment with Y-27632 maintained the arterial diameter by preventing FBS-induced gradual
arterial constriction during organ culture. Y-27632 also reduced the apoptosis and the loss of contractile myosin
and actin filaments of smooth muscle cells. In addition, Y-27632 protected the morphological integrity between the
endothelial cell layer and smooth muscle cell layer by preventing endothelial cell detachment and platelet
endothelial cell adhesion molecule (PECAM) expression decrement.
Conclusions: Chronic ROCK inhibition provides protective effects against FBS-stimulated structural in addition to
functional alterations of vascular smooth muscle cells and endothelial cells. These results strongly suggest that the
RhoA/ROCK signaling is crucial for maintaining the structural and functional phenotypes of vasculature, and hence,
chronic ROCK inhibition may provide protective effects on excessive growth factor-related vascular diseases
including hypertension and atherosclerosis.
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Background
Sustained vasoconstriction and vascular remodeling play
important roles in the pathogenesis of vascular diseases
such as hypertension, vasospasm, and atherosclerosis
(Schwartz 1997; Noma et al. 2006). Recent studies provided
better understanding of the pathophysiological mechanisms
involved in vascular dysfunction. However, cardiovascular
disease is the number one cause of death throughout
the world (World Health Organization 2011). Further
studies are needed in order to clarify the mechanism
that causes vasoconstriction and vascular remodeling-
induced cardiovascular disease.
Ras homolog gene family member A (RhoA) acts as a
molecular switch that regulates smooth muscle contraction
(Brown et al. 2006), and Rho-associated kinase (ROCK),
a RhoA effector, contributes to various physiological
functions in blood vessels including endothelial and
smooth muscle cells (Noma et al. 2006). Therefore, the
RhoA/ROCK signaling pathway is proposed to play a
pivotal role in diverse cellular functions, including
expression and activity of endothelial nitric oxide synthase,
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vascular smooth muscle contraction, actin cytoskeleton
organization, cell adhesion and motility, proliferation, and
hypertrophy in smooth muscle cells (Noma et al. 2006;
Somlyo and Somlyo 2003; Gerthoffer 2007). Although
deletion of either ROCK1 or 2 causes, respectively,
embryonic and postnatal death in mouse models,
abnormal upregulation of the RhoA/ROCK signaling
pathway induces various vascular dysfunctions (Schwartz
1997; Félétou and Vanhoutte 2006; Cicek et al. 2013),
which suggests that control of RhoA/ROCK signaling
pathway or RhoA and/or ROCK expression itself is a
useful therapeutic target in cardiovascular diseases
(Noma et al. 2006; Cicek et al. 2013; Shimokawa and
Takeshita 2005; Loirand et al. 2006).
To address the underlying mechanisms by which the
upregulation of RhoA/ROCK signaling causes abnormal
contractility of the vascular smooth muscle and following
vascular disease, various studies were carried out by the
use of an animal model and isolated or cultured cell
model. In an animal model, the beneficial effect of
ROCK-inhibiting compounds including Y-27632 has
been reported on various cardiovascular diseases such
as hypertension, coronary and cerebral vasospasm, and
pulmonary arterial hypertension (Uehata et al. 1997;
Shimokawa and Rashid 2007). In vitro cell culture models
also have been used extensively to elucidate the molecular
mechanism governed by RhoA/ROCK signaling with
finely tuned culture conditions (Chen et al. 2010; Singh
et al. 2011; Pagiatakis et al. 2012). However, both
approaches have particular limitations. For in vivo animal
models, the underlying mechanisms on the effects of
ROCK inhibitors are difficult to identify because disease
conditions are difficult to control and many factors can be
involved. In the case of in vitro cell culture models, it is
difficult to regenerate the contractile machinery in smooth
muscle cells and the smooth muscle cell-endothelial cell
interactions. In addition, smooth muscle cells in culture
rapidly transform their phenotypes from contractile to
synthetic (Somlyo and Somlyo 2003; Owens et al. 2004;
Woodsome et al. 2006). Thus, organ culture of the vas-
culature has been used as an alternative method that
can complement the limitations of animal- or cultured
cell-based studies for investigating the chronic treatment
effects of various inhibitors in arterial tissues (Ozaki and
Karaki 2002; Thorne and Paul 2003; Huh et al. 2011).
Recently, using an organ culture model, we have
reported that the ROCK inhibitor Y-27632 preserved the
small mesenteric arterial rings from 1-week fetal bovine
serum (FBS)-supplemented culture-induced functional
abnormalities, such as gradual arterial constriction, wall
thickening, reduced contractile activity, downregulation
of endothelial nitric oxide synthase (eNOS), reduction
of endothelium-induced relaxation, and increased ROCK-
specific myosin phosphatase targeting subunit 1 (MYPT1)
Thr 853 phosphorylation (Huh et al. 2011). In this report,
we further expanded the previous functional study to a
structural study. We tested whether inhibition of ROCK
mitigates the effect of the growth stimulant FBS on the
structure of differentiated smooth muscle and endothelial
cells in peripheral arteries, which primarily regulate blood
pressure. Here, we report that the ROCK inhibitor Y-
27632 prevents the detachment and loss of the endothelial
cell layer, the disappearance of contractile thick and
thin filaments, and apoptosis and necrosis. These results
strongly suggest that the RhoA/ROCK signaling is crucial
for maintaining the structural and functional phenotypes
of the vasculature and hence has the potential to be a
therapeutic target in cardiovascular diseases.
Methods
Animals and mesenteric artery preparation
All animal procedures for the isolation of arteries from
rabbits were approved by the Animal Care and Use
Committees of the Boston Biomedical Research Institute.
The detailed procedures for isolation of arterial rings
and organ culture have been described previously (Huh
et al. 2011). Briefly, the rabbits were euthanized with an
overdose of halothane. After thoracotomy, the mesenteric
arteries were isolated and surrounding fat and fluffy
connective tissues were discarded. To choose which
segment in a mesenteric arterial tree is apt to conduct
the morphofunctional studies using organ culture system,
we first analyzed the gross morphology and protein
expression of the main artery and first and second
branches of the rabbit mesenteric artery. In the
hematoxylin and eosin-stained low- and high-magnification
images, no morphological difference between the main
and branched mesenteric artery was noted except for
the number of smooth muscle cell layers in the section
(Figure 1A). Moreover, the contractile protein expressions
related to the RhoA/ROCK signaling pathway were quite
similar (Figure 1B,C). Based on these data, we chose
the first branches of the mesenteric artery for organ
culture because the inner and outer diameters were more
uniform than the main artery and second branches of
the mesenteric artery regardless of the region.
Organ culture procedure
To set up the organ culture condition, the first branches
of the mesenteric artery were cut into rings (0.5~0.6 mm
in outer diameter and 0.75 mm in length). The arterial
rings were then placed in a silicone elastomer dish
containing 4 ml of Dulbecco's modified Eagle's medium
(DMEM) supplemented with 50 U penicillin, 50 μg/ml
streptomycin, and 10% FBS (Sigma-Aldrich Co., St. Louis,
MO, USA; cat# F4135) with or without 10 μM Y-27632.
The arterial rings were maintained at 37°C with 5% CO2
for 7 days. The culture medium was changed every 2 days.
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During the culture, each ring was loosely laid and
placed on the silicone elastomer and secured by a pin at
the center of the lumen without stretching (see Figure 2A).
Once or twice a day during culture, the medium was
gently shaken and the rings were moved around the
supporting pin to prevent it from attachment to the
silicone dish and subsequent cell migration.
Artery immunohistochemistry
For immunohistochemistry analysis, the stretched arterial
rings on the force transducer were fixed with 4% para-
formaldehyde in phosphate-buffered saline (PBS) solution
for 30 min at 30°C. Then, the pre-fixed rings were
removed from the apparatus and further fixed with 4%
paraformaldehyde for 2 h at 4°C. After three washes in
PBS, the rings were embedded in the Tissue-Tek optimal
cutting temperature (OCT) compound (Fischer Scientific,
Waltham, MA, USA), frozen in liquid nitrogen-cooled
isopentane, and kept at −80°C for future use. The cryostat
sections (10 μm) were collected on glass slides, washed
with PBS to remove OCT compound, treated with 0.2%
Triton X-100, and washed with PBS. The sections were
then incubated in the blocking solution (PBS containing
10% goat serum, 5% milk, and 4% bovine serum albumin
(BSA)) for 1 h at room temperature and treated with
the primary antibody solution (PBS containing 0.1%
Tween-20 and 2% BSA) for overnight at 4°C in humidified
chambers. After rinsing with PBS containing 0.5% BSA,
the sections were treated with fluorescence-conjugated
secondary antibody (Invitrogen, Inc., Carlsbad, CA, USA).
After washing, the sections were counterstained with
4′,6-diamidino-2-phenylindole (DAPI) and mounted with
FluorSave mounting medium (Millipore Corp., Billerica,
MA, USA). Epifluorescence images were captured with a
Leica DMR fluorescence microscope and a Leica DC300F
digital camera system (Leica Microsystems Ltd., Milton
Keynes, UK).
Immunoblotting
Immunoblotting experiments were performed as previously
described (Kitazawa et al. 2003). Briefly, the arterial rings
were isolated from the main artery and first and second
Figure 1 Gross morphology and contractile protein expression in the rabbit mesenteric artery. (A) To compare the gross morphology, the
isolated main artery and first and second branches of the rabbit mesenteric artery were embedded in the same OCT block, and the collected
cryosections were stained with hematoxylin and eosin. The high-magnification images of the boxed regions (1, 2, 3) are displayed below. (B, C)
Representative immunoblot images and a quantitative summary for relative contractile protein expression (n = 4). The protein expressions of the
main artery and first and second branches of the mesenteric artery were compared after matching the pan-actin expression. For actins, protein
extracts that were diluted tenfold were loaded.
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branches of the mesenteric artery, and they were quickly
frozen in liquid nitrogen and kept in 10% trichloroacetic
acid (TCA)-acetone at −80°C overnight. After the TCA
treatment, the tissues were gradually warmed and washed
in acetone at room temperature, and allowed to dry. The
small dried rings were homogenized in a Laemmli sample
buffer (LSB; with final concentrations of 62.5 mM Tris,
1% SDS, 15% glycerol, 30 mM dithiothreitol, and 0.005%
bromophenol blue) using a glass-glass mini homogenizer.
The homogenates were then centrifuged and the superna-
tants were collected. The total protein concentration was
measured using a Coomassie Plus Protein Assay Reagent
Kit (Pierce, Rockford, IL, USA) and adjusted to 2 mg/ml
with LSB. For the actin, the samples were diluted tenfold
with LSB. The proteins were separated on a 4% to 20%
polyacrylamide gradient gel and then transferred to nitrocel-
lulose membranes using a wet transfer method. The mem-
branes were blocked in Tris-buffered saline (TBS) solution
containing 0.05% Tween-20 and 5% non-fat milk for 1 h at
room temperature. After the treatment with the primary
antibody solution, the membranes were incubated with al-
kaline phosphatase-conjugated secondary antibodies, and
the bands were developed with alkaline phosphatase sub-
strate (Sigma-Aldrich Co., St. Louis, MO, USA). The bands
were scanned and analyzed using the IPLabGel image ana-
lyzing system (Signal Analytics, Vienna, VA, USA).
Apoptosis detection by the TUNEL assay
For the in situ apoptosis detection at the cellular level,
we used the ApopTag red in situ apoptosis detection kit
(Chemicon International, Temecula, CA, USA) for the
terminal deoxynucleotide transferase dUTP nick end
labeling (TUNEL) assay. Briefly, the cryostat sections
(10 μm) from the 7 days organ-cultured arterial rings
with or without 10 μM Y-27632 were obtained. The
sections from the fresh mesenteric artery and the
artery cultured in 1 μM angiotensin II-containing
medium for 7 days were used as the negative and
positive control, respectively. The tissue sections were
fixed in 1% paraformaldehyde for 2 h at 4°C. After
three washes in PBS (5 min each), the tissues were
post-fixed with a mixture of ethanol and acetic acid
(at a ratio of 2:1) at −20°C for 5 min and washed
three times (5 min each). The tissues were then incu-
bated with the terminal deoxynucleotidyl transferase
(TdT) enzyme in a humid atmosphere for 60 min at 37°C.
After incubation for 30 min with a rhodamine-labeled
anti-digoxigenin conjugate and following counterstaining
with DAPI, the sections were mounted with a FluorSave
mounting medium (Millipore Corp., Billerica, MA,
USA). Slides were viewed and imaged with a fluores-
cence microscope (Leica DMR) and a digital camera
(Leica DC300F) system.
Figure 2 Effects of 10 μM Y-27632 on FBS-induced shrinkage in organ-cultured rabbit mesenteric arterial rings. (A) Diagram
for experimental design. The arterial rings that were isolated from the first branch of the rabbit mesenteric artery were cultured with an
FBS-supplemented DMEM in the absence and presence of 10 μM Y-27632. (B) Representative arterial ring images from days 1, 4, and 7 in an
FBS-supplemented DMEM in the absence (top) and presence (bottom) of Y-27632. The dark spot in the lumen of the arterial ring is the image of
a supporting pin, and the background in the each image is the part of the index number written at the bottom of the organ culture plate. (C)
Representative immunofluorescence images acquired from the longitudinally sectioned area of arterial rings in each experimental condition. The
images of the filamentous actin (red), elastin (green), and nucleus (blue) were overlaid. (D) Quantitative summary for the smooth muscle cell
number per unit area of the smooth muscle layer between the experimental groups. For average, the smooth muscle cell numbers per unit area
of the freshly isolated smooth muscle layer were normalized to 100%. The results are expressed as mean ± S.E.M. (n = 4).
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Transmission electron microscopy
For transmission electron microscope (TEM) analysis,
mesenteric arterial rings in different organ culture con-
ditions were mounted on the force transducer setup
and stretched to adjust the muscle length as described
previously (Kitazawa et al. 2009). The fresh arterial
rings were stretched to 1.2 times their original slack
length and the organ-cultured rings were stretched to
the same tension level as that of the fresh one. The
stretched arterial rings were fixed for 30 min at 30°C in
pre-warmed 0.1 M sodium cacodylate buffer containing
2% glutaraldehyde, 2% paraformaldehyde, and 3.5% sucrose
while they were stretched on the force transducer. Then,
the pre-fixed rings were removed from the apparatus and
further fixed in the same fixing solution for 2 h at 4°C with
agitation. After three washes in 0.1 M sodium cacodylate
buffer (10 min each), the rings were post-fixed with 1%
osmium tetroxide on ice for 2 h and washed three times
(10 min each) with a 0.1 M sodium cacodylate buffer. After
gradual dehydration in an ethanol and propylene oxide
series, the rings were then embedded in an Epon 812 mix-
ture and polymerized in an oven at 60°C for 24 h. The em-
bedded blocks were then sectioned on an ultramicrotome
with a diamond knife, and ultrathin sections were collec-
ted on collodion-coated copper grids. The sections were
stained with 2.5% uranyl acetate (7 min) and Reynolds lead
citrate (2 min) and were examined using a TEM (Technai
G2 Spirit Twin, FEI, Hillsboro, OR, USA) at 120 kV.
Antibodies
The following primary antibodies were used in this study:
polyclonal anti-MYPT1 (BabCO, Richmond, CA, USA,
1:5,000), anti-CPI-17 IgY (1:5,000), polyclonal anti-
caldesmon (from Dr. A. Wang of BBRI, 1:10,000), poly-
clonal anti-h-calponin (from Dr. E. Mabuchi of BBRI,
1:10,000), polyclonal anti-PKCα (Sigma, St. Louis, MO,
USA, 1:1000), polyclonal anti-PP1Cδ (from Dr. Eto of
Thomas Jefferson University, 1:5,000), polyclonal anti-
ROCK1 (Sigma, St. Louis, MO, USA, 1:2,000), monoclonal
anti-RhoA (Santa Cruz Biotechnology, Dallas, Texas, USA,
1:1,000), polyclonal anti pan-actin (Sigma, St. Louis, MO,
USA, 1:1,000), monoclonal anti α-actin (Sigma, St. Louis,
MO, USA, 1:5,000), and polyclonal anti-platelet endothelial
cell adhesion molecule (PECAM)-1 (Santa Cruz Biotech-
nology, Dallas, Texas, USA, 1:1,000). The secondary anti-
body against chicken IgY was from Promega (Madison, WI,
USA, 1:5,000). The anti-mouse and anti-rabbit IgG second-
ary antibodies (1:5,000) were from Chemicon (Billerica,
MA, USA).
Statistics
The results are expressed as mean ± S.E.M. of n experi-
ments. Statistical significance was evaluated with one-way
ANOVA; P < 0.05 was considered statistically significant.
Results
Effect of Y-27632 on the FBS-induced contraction of the
organ-cultured artery
To examine the morphological changes in the arterial
rings during the FBS-supplemented organ culture, the
isolated arterial rings were cultured for 7 days with 10%
FBS-supplemented DMEM with or without 10 μM Y-
27632 (Figure 2A). Then, we obtained an image of each
arterial ring every 24 h to analyze the changes in outer
and inner diameters (i.e., thickness) of the arterial wall
(Figure 2B). We first confirmed the previous findings
(Huh et al. 2011) that the arterial rings organ-cultured
in the 10% FBS medium in the absence of Y-27632, the
inner diameter shrank to about half at day 4, and the
lumen was completely obstructed on day 7 (Figure 2B,
top panel). On the other hand, 10 μM Y-27632 markedly
reduced the gradual shrinkage of the organ-cultured
arterial rings and the changes in the arterial wall
thickness (Figure 2B, bottom panel).
Then, we check precisely whether the shrinkage of ar-
terial rings cultured with FBS in the absence of Y-27632
was mediated by smooth muscle cell migration to the
culture plate from the tunica media possibly by the FBS-
mediated phenotypic change. All arterial rings used for
the organ culture were fixed and double-stained with anti
α-actin antibody and DAPI, and the total cell number in
the whole cross-sectional area of the tunica media was
counted (Figure 2C). The total number of DAPI-stained
nuclei in the tunica media of the arterial rings cultured
for 7 days with FBS in the absence of Y-27632 (81 ±
9% of fresh, n = 4) and in the presence of Y-27632 (85 ±
14% of fresh, n = 4) was not significantly different from
that of the freshly isolated mesenteric artery (Figure 2D).
Y-27632 effect on the maintenance of the endothelial
cell and smooth muscle cell integrity in the
organ-cultured artery
We showed previously that Y-27632 prevented FBS-
induced decrease in the eNOS mRNA expression and the
acetylcholine (Ach)-induced relaxation (Huh et al. 2011).
To examine whether Y-27632 also prevented FBS-induced
structural alteration of the endothelial cell layer, the freshly
isolated and organ-cultured mesenteric arteries that
had been tested for Ach-induced relaxation were fixed
and longitudinally (parallel to the longitudinal axis of
the smooth muscle) sectioned for immunohistochemical
analysis. Figure 3A shows the fluorescence images of the
arterial section representing the anti-PECAM-stained
endothelial cells, auto-fluorescencing elastin layer, DAPI-
stained nucleus, and merged images, respectively. In the
freshly isolated mesenteric artery, one continuous PECAM
layer (red, left image of top panel) was coincident with
one side of the auto-fluorescencing elastin lines (green,
left image of second panel), which suggests that the
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endothelial cell layer fully covers the tunica intima and
is tightly associated with the elastin layer (left image of
bottom panel). By contrast, in the organ-cultured artery
with FBS in the absence of Y-27632, approximately half of
the endothelial cell layers were missing (middle image of
top panel) and the remaining PECAM-positive layers
were only loosely associated with the auto-fluorescencing
elastin layer (middle image of bottom panel). This result
suggests that considerable numbers of endothelial cells
were already absent and the remaining layers were not
tightly associated with the internal elastic layer. In the
presence of Y-27632, however, majority of the endothelial
cell layers except the small areas unstained to the PECAM
(right image of top panel) were tightly adhered to the
elastin layer along the luminal side of the vascular wall
(right image of bottom panel).
To confirm the immunohistochemical results, we per-
formed immunoblotting and determined the changes
in the PECAM expression during organ culture. The
PECAM expression in the organ-cultured artery without
Y-27632 was significantly decreased to about half, whereas
the PECAM expression was maintained at a level similar
to that of the fresh mesenteric artery in the presence of
10 μM Y-27632 (Figure 3B). These results are consistent
with the previous functional finding on ACh-induced
relaxation (Huh et al. 2011).
Y-27632 effect on the apoptotic and ultrastructural
degeneration in the organ-cultured mesenteric artery
We showed previously that the artery organ-cultured
with FBS for 7 days reduced both depolarization- and
agonist-induced contractions and that Y-27632 significantly
prevented the FBS-induced reduction of contraction (Huh
et al. 2011). To test the hypothesis whether FBS treatment
prompted and Y-27632 prevented cell death and/or
phenotypic change during organ culture, we performed
the apoptosis assay using the TUNEL method (Figure 4).
To delineate the smooth muscle-containing tunica media,
nuclei were counterstained with DAPI and the elastin
autofluorescence was captured. Then, the apoptotic cells
in the tunica media of each experimental condition were
counted, respectively. The FBS-containing organ culture
increased the number of TUNEL-positive apoptotic cells
to 17 ± 2% (n = 7) of the total cells counted in the tunica
media (second panel of Figure 4A), whereas Y-27632
limited apoptotic cells in the tunica media to 5 ± 2%
(third panel of Figure 4A) as compared to a negligible
background level (1 ± 0%) in the freshly isolated mesen-
teric artery. We used the arterial rings that were cultured
with 1 μM angiotensin II (AT II) as a positive control
sample (Best et al. 1999) to confirm the assay efficiency
(n = 7; bottom panel of Figure 4A). Angiotensin II
drastically increased the apoptotic cell fraction to 71 ± 3%
in the tunica media (Figure 4B).
Although RhoA and ROCK are upregulated and MYPT1
is phosphorylated in the chronic FBS organ culture
conditions, the extent of contraction induced by agonists
such as the α1-agonist is significantly lower after FBS
treatment. This may be partly due to about 50% reduction
in expression of the myosin light chain (MLC) and
CPI-17 (Huh et al. 2011). We further tested whether
the ultrastructural integrity of smooth muscle cells is
Figure 3 Effect of 10 μM Y-27632 on the maintenance of endothelium integrity in organ-cultured mesenteric arteries. (A) Representative
images of the endothelial layer that were immunostained with anti-PECAM (CD31) antibody in the longitudinal sections of freshly isolated and
organ-cultured mesenteric arteries. To verify the morphological integrity of the endothelial cell layer, elastin autofluorescence (Auto Fl; green) and
cell nucleus (DAPI; blue) were also captured with PECAM (red). (B) Representative immunoblot images of PECAM and calponin (as a loading
marker) and a quantitative summary (lower) for the relative PECAM expression (n = 3). The asterisk represents a significant (P < 0.05) difference
from that of the fresh mesenteric artery. The number sign represents a significant (P < 0.05) difference from that of the FBS-supplemented organ-
cultured mesenteric artery in the absence of Y-27632.
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impaired with FBS treatment. The mesenteric arterial
rings were fixed under optimally stretched conditions
(see ‘Methods’ section) for TEM analysis (Figure 5). At
low-magnification images (Figure 5A,B,C), 33 ± 2% (n = 4)
of the smooth muscle cells in the organ-cultured arteries
with FBS in the absence of Y-27632 were markedly
swollen and had reduced cytoplasmic density with fewer
organelles including contractile filaments (Figure 5B).
No such cells were found in the fresh mesenteric artery
(Figure 5A), which suggests that the necrotic smooth
muscle cells were induced during the FBS organ culture.
On the other hand, most smooth muscle cells in the
organ-cultured arteries with 10 μM Y-27632 maintained
structural integrity of smooth muscle cells except with
increased extracellular space (Figure 5C), which corre-
sponds to a mild arterial wall thickening (Figure 2B).
At higher magnification images (Figure 5D,E,F,G), the
bulk of the cytoplasm was filled with contractile thick
and thin filaments and dense bodies in the smooth muscle
cells of the mesenteric arteries cultured with 10 μM
Y-27632 (Figure 5F) as well as those of the fresh mesen-
teric arteries (Figure 5D). By contrast, in the cultured
mesenteric artery without Y-27632, both the contractile
filaments and dense bodies were not observed in the
swollen and lightly stained cells (Figure 5G, cells marked
with an asterisk in Figure 5B), whereas the other darkly
stained cells in Figure 5B still retained normal thick
and thin filaments and dense bodies in the cytoplasm
(Figure 5E), as seen in the fresh mesenteric arteries.
Discussion
In this study, we used an organ culture system of differ-
entiated mesenteric arterial vessels as a physiological
model that is reasonably closer to the in vivo environment
than the cell culture system. The chronic treatment
with the growth stimulant FBS impairs contractility,
morphological alteration, and DNA synthesis of arteries
during organ culture (Huh et al. 2011; Lindqvist et al.
1999; Murata et al. 2005). To evaluate whether the
inhibition of RhoA/ROCK signaling pathway prevents the
structural alterations of the artery, we organ-cultured
arteries in the presence of ROCK inhibitor Y-27632, to-
gether with FBS. Y-27632 prevents the detachment and
loss of the endothelial cell layer, the disappearance of
contractile thick and thin filaments of smooth muscle
cells, and the apoptosis and necrosis during chronic
FBS-supplemented organ culture.
According to our previous organ culture study, chronic
treatment with Y-27632 protects almost all functional
integrities of both endothelial and smooth muscle cells,
including excitatory agonist-induced contraction and
ACh-induced relaxation (Huh et al. 2011). Y-27632 also
successfully inhibited the FBS-induced gradual arterial
constriction during organ culture for 7 days. In addition,
H-1152, another ROCK inhibitor, and simvastatin, which
inhibit RhoA geranylgeranylation (Noma et al. 2006), also
showed a significant inhibitory effect on the FBS-induced
arterial constriction (Huh et al. 2011). Consistent with
those previous works, the present study demonstrated that
Figure 4 Effect of 10 μM Y-27632 on the apoptotic degeneration of organ-cultured rabbit mesenteric arteries. (A) Cross-sections of the
freshly isolated and organ-cultured mesenteric arteries were stained using the TUNEL method. The cell nuclei were counterstained with DAPI, and
the elastin autofluorescence was captured to define the tunica media. To validate the TUNEL assay results, we used the arterial rings cultured
with 1 μM angiotensin II (AT II) as the positive control sample. The representative TUNEL (red) images merged with the DAPI (blue) and
autofluorescence (green) images. (B) Statistical analysis of TUNEL data in the tunica media under each condition (n = 7). The asterisk represents a
significant (P < 0.05) difference from that of the fresh mesenteric artery on D0. The number sign represents a significant (P < 0.05) difference from
that of the FBS-supplemented organ-cultured mesenteric artery in the presence of Y-27632.
Huh et al. Journal of Analytical Science and Technology Page 7 of 102013, 4:15
http://www.jast-journal.com/content/4/1/15
Y-27632 markedly reduced the morphological alterations
in the organ-cultured arterial rings. Interestingly, chronic
treatment with Y-27632 did not prevent the FBS-induced
overexpression of RhoA and ROCK but rather augmented
the expressions to higher levels than those of FBS alone
(Huh et al. 2011). Considering that the Y-27632 effectively
protects the organ-cultured artery against FBS-induced
gradual arterial constriction (Figure 2B), inhibition of
the downstream signaling of upregulated RhoA/ROCK
may be a major cause for preventing arterial constriction
even in higher expression of RhoA and ROCK.
Endothelial cells regulate vascular tone and permeability
by producing nitric oxide (NO) (Félétou and Vanhoutte
2006), but the upregulated RhoA/ROCK signaling pathway
leads to impaired NO production by suppressing eNOS
expression or inhibiting eNOS activity (Noma et al. 2006;
Murata et al. 2005; Bolz et al. 2003). Thus, the ROCK
inhibitors have been proposed as a therapeutic agent
for cardiovascular diseases (Noma et al. 2006; Shimokawa
and Takeshita 2005; Loirand et al. 2006). In the case of
type 1 diabetes, dysfunction of endothelial cells plays a
key role in the pathogenic disorder of vasculature. The
upregulation of ROCK and the reduction of the en-
dothelial NO production are closely associated by the
involvement of RhoA/ROCK signaling pathway, while
suppressing ROCK activity restores vascular function
(Cicek et al. 2013; El-Remessy et al. 2010; Kizub et al.
2010; Yao et al. 2013). In the present study, majority
of endothelial cell layers were tightly adhered to the
elastin layer in the presence of Y-27632, and PECAM
expression was also maintained at a level similar to that of
the fresh mesenteric artery (Figure 3). These results are
consistent with our previous report on the protective
role of Y-27632, such as maintenance of eNOS mRNA
expression and endothelial cell-mediated relaxation in
the organ-cultured mesenteric artery (Huh et al. 2011).
Together with our previous report, the present study
shows that chronic treatment with Y-27632 protects
not only functional but also structural integrities of
endothelial cells. Whether Y-27632-induced protection
of eNOS mRNA (Huh et al. 2011) and PECAM expres-
sion in endothelial cells is caused by or independent
Figure 5 Representative TEM micrographs of cross-sectioned smooth muscle cells from freshly isolated and organ-cultured rabbit
mesenteric arteries. Representative low-magnification images of (A) freshly isolated, (B) FBS-supplemented, and (C) FBS with Y-27632-
supplemented organ-cultured arterial smooth muscle cells, respectively. (D-F) Representative high-magnification images of the darkly stained cells
in (A-C), respectively. (G) A high-magnification image of the lightly stained swollen cells (cells marked with an asterisk in (B)). The asterisk
represents the swollen cells in (B) and (C). DB, dense body. Scale bars = 5 μm (A-C) and 200 nm (D-G).
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from maintaining adherence of endothelial cell layers
to the smooth muscle cell layers is unclear but warrants
examination.
According to recent studies, the inhibition of RhoA/
ROCK signaling pathway promotes the apoptosis of
gastric cancer cells (Xiao-Tao et al. 2012). By contrast,
inhibition of RhoA/ROCK signaling decreased the neur-
onal apoptosis in the ischemic penumbra of the rat brain
and the penile apoptosis in the cavernous nerve injury
model (Wu et al. 2012; Hannan et al. 2013). In the present
study, Y-27632 drastically decreased the FBS-induced
apoptosis of smooth muscle cells and endothelial cells
in the organ-cultured mesenteric artery (Figure 4). This
finding may provide another beneficial effect that the
inhibition of RhoA/ROCK signaling pathway by Y-
27632 protects the artery by preventing the apoptosis
of both smooth muscle cell and endothelial cell even
though the mechanism for ROCK-induced apoptosis
needed to be further addressed.
In vascular diseases, the phenotype of smooth muscle
cells is easily changed from contractile to synthetic/
proliferative with the loss of contractile filaments in
response to various stimuli including growth factors.
These phenotypic changes are associated with the
downregulation of α-actin and h-caldesmon and the
upregulation of RhoA and ROCK (Gerthoffer 2007;
Owens et al. 2004; Woodsome et al. 2006). In our pervious
organ culture study, RhoA and ROCK expression and
MYPT1 phosphorylation increased, but the expression
of α-actin decreased upon chronic FBS treatment.
Moreover, the expression of MLC and CPI-17 also
decreased to about 50%, both of which have an essential
function in the development of vascular smooth muscle
contraction (Dimopoulos et al. 2007), but the decrease
of MLC and CPI-17 expression was prevented in presence
of Y-27632 during organ culture (Huh et al. 2011). To
address the effect of the changes in contractile protein
expressions on the structural integrity of contractile
filaments, we performed the TEM analysis of organ-
cultured arterial smooth muscle cells (Figure 5). The
TEM analysis showed that smooth muscle cells in the
FBS-supplemented organ culture were markedly necrotized
with contractile filament loss (Figure 5B,G), consistent
with the previous report by Lindqvist et al. (1999). How-
ever, 10 μM Y-27632 maintained the structural integrity
of the smooth muscle cells with intact actin and myosin
filaments (Figure 5C,F). These findings suggest that the
overexpression of RhoA and ROCK and the down-
expression of α-actin, MLC, and CPI-17 are closely related
with the loss of contractile actin and myosin filament
in organ-cultured smooth muscle cells, as shown in
the TEM results of the present study (Figure 5G). In
addition, the inhibition of the upregulated RhoA/ROCK
signaling pathway and the maintenance of MLC and
CPI-17 expression by the chronic treatment with Y-27632
may play a significant role in the prevention of FBS-
induced contractile filament deterioration.
Conclusions
The findings of the present study provide structural
evidence that inactivation of a pathophysiologically
important RhoA/ROCK signaling pathway by Y-27632
prevents FBS-supplemented organ culture-induced arterial
damages. Y-27632 effectively maintains the arterial
diameter and the structural integrity of adhesion of
endothelial cells to smooth muscle cells. Also, Y-27632
prevents the apoptosis of both endothelia and smooth
muscle cells and the ultrastructural degeneration of
contractile actin and myosin filaments in smooth muscle
cells. Together, these results suggest that the chronic
inhibition of the RhoA/ROCK signaling pathway by in-
hibitors such as Y-27632 produces preventive effects on
FBS-induced vascular complications and could offer a
therapeutic means for RhoA/ROCK-mediated vascular
diseases, such as hypertension and vasospasm.
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